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1. Introduction 2. Materials and methods 
According to our present knowledge about steroid 
hormone action specific receptors play a pivotal role 
in the biochemical mechanism of action (reviews 
[l-3]). Following its entry through the plasma 
membrane of a target cell the steroid is bound by 
intracellular receptors. Subsequently, the receptor- 
hormone complex is transferred to the cell nucleus 
and interacts with chromatin to bring about changes 
in specific gene expression. The receptor therefore 
has to be regarded as a molecular entity which com- 
prises 2 active domains: one for steroid binding and 
the other for nuclear interaction [4,5]. 
2.1. Cell lines and culture conditions 
The mouse lymphoma line WEHI- [7] was kindly 
provided by Dr A. W. Harris. The 849.1 lymphoma 
sublines were those in [8,9]; their phenotypes are 
listed in table 1. Cells were grown and harvested as in 
[lo] and stored frozen at -90°C. 
2.2. Cytosol preparations 
The growth inhibitory effect elicited by glucocor- 
ticoids in certain cells of lymphatic origin has been 
used to select for unresponsive ariant cells with alter- 
ations in their receptors (reviews [5,6]). Although the 
majority of these variants is characterized by negligible 
receptor binding activities, several variants have been 
obtained with roughly normal steroid binding but 
abnormal interaction of the receptor complexes with 
cell nuclei, chromatin or DNA. In one such pheno- 
type the receptor-glucocorticoid complex is defec- 
tive in nuclear binding (nt-, nuclear-transfer deficient) 
while in another increased nuclear binding and 
increased affinity for DNAare observed (nt’, increased 
nuclear transfer). 
Frozen cell pellets were thawed and homogenized 
at 0°C in 20 mM tricine buffer (PH 7.4) containing 
50 mM KCl, 5 mM dithioerythrol and 10% glycerol 
using a Dounce homogenizer. Following centrifuga 
tion at 100 000 X g for 90 min the clear supernatant 
was removed and used for binding studies. Through- 
out these experiments cytosols were prepared in such 
a way that 300 d corresponded to 10’ cells. 
2.3. Binding assays 
Here, we ask the question whether defects in the 
nuclear interaction domain of the receptor would 
also lead to alterations, albeit subtle, in the steroid 
binding site. The technique we applied was to mea- 
sure the kinetics of receptor-steroid interaction. In 
one clone of nt- phenotype we indeed found a sig- 
nificant difference in the dissociation of the receptor- 
steroid complex while in other variants the kinetics 
had wild-type characteristics. 
Samples (300 4) of cytosol were incubated at 0°C 
with various concentrations of [ 3H] dexamethasone 
(Amer.&am, 25 Ci/mmol) with or without a 1 OOO-fold 
excess of non-radioactive dexamethasone asa com- 
petitor. Specific binding was assessed from the differ- 
ence of hormone binding in noncompeted and com- 
peted samples [ 111. All samples were in duplicate. 
Following the addition of 50 d dextran-coated 
charcoal (100 mg Norit A and 5 mg dextran T-500 
(Pharmacia)/ml) the samples were agitated for 5 s and 
centrifuged for 5 min in a table-top centrifuge. Radio- 
activity was determined in the supernatant using a 
Triton X-l 00 containing scintillant and a Beckman 
L8 7000 liquid-scintillation counter at 43% efficiency. 
For equilibrium binding experiments incubations 
were for 15 h; the data were evaluated by the Scatchard 
method [ 121. Association kinetics were measured 
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in cytosol preparations exposed to [ 3H] dexamethasone 
at 1 O-30 nM; samples were removed at intervals and 
assayed as described. Association rate constants k, 
were obtained as in [ 131 assuming receptor saturation 
after 3-4 h incubation. Dissociation kinetics were 
measured in cytosol preparations preequilibrated 
with 50 nM [ 3H] dexamethasone for 90 mm; follow- 
ing the addition of a 1 OOO-fold excess of unlabelled 
steroid, specific binding was determined at intervals 
using the charcoal assay. 
3. Results 
3.1. Association of dexamethasone with receptors 
Three glucocorticoid-sensitive sublines of the 
849.1 mouse lymphoma were used here. Their recep- 
tors were compared to those of the WEHI- thymic 
lymphoma celI line which is known to contain roughly 
double the level of intracellular receptors of indistin- 
guishable binding characteristics [ 14,151. Three 
glucocorticoid-resistant clones of 849.1 were also 
investigated (table 1). The binding of radiolabelled 
dexamethasone to receptors contained in cytosol 
preparations i  shown in fig.1 A for 4 representative 
cell clones. Saturation of receptors was attained by 
2-3 h. The kinetic data obtained for the initial 
60 min incubation were evaluated from a linearized 
plot [ 133 assuming second-order kinetics (fig.1 B). 
The results are compiled in table 1. The association 
rate constant k, for the formation of the receptor- 
dexamethasone complex was -1 X lo8 mm-‘. M-’ 
for all cell clones tested. This value is of the same 
order of magnitude as those reported for dexametha- 
sone binding to receptors of various other cell types 
[16-201. 
3.2. Dissociation of receptor-dexamethasone 
complexes 
Dissociation of preformed receptor complexes 
with radiolabelled examethasone was measured by 
following the displacement by unlabelled steroid that 
had been added in excess. As depicted in fig.2 for 5 
cell clones the kinetics was first order. Dissociation 
rate constants k, calculated from the slopes of such 
semilogarithmic plots are listed in table 1. For all cell 
lines except one the rate constant was -1 X 10m3 
min-’ with half-times of dissociation of -5 h. The 
complex of one of our nt- clones, 849.1TB.4.22R, 
however, dissociated much faster (fig.2, table 1); the 
half-life of the complex was found to be 76 min only. 
3.3. Equilibrium dissociation constant 
The kinetic constants for dexamethasone i terac- 
tion with receptors were used to compute the equilib- 
rium dissociation constant K, for the complexes 
(table 1). For the nt- line 849.1TB.4.22R the K, was 
-3-fold different from those of the others. For com- 
parison, K, values were also determined by equilib- 
rium binding experiments (not shown). In general, 
Kd-values obtained from association and dissociation 
kinetics are regarded to be more accurate than those 
measured by equilibrium binding [ 18,20,21] because 
of the instability of unbound glucocorticoid receptors 
during long incubation times and at low steroid con- 
60 
Fig.1. Kinetics of dexamethasone association with receptors. 
Cytosols of WEHI- (m), S49.1TB.4 (0). S49.1TB.4.22R (A) 
and S49.1TBA.SSR (0) were incubated with [‘Hldexametha- 
sone at lo-30 nM. Samples were removed at intervals and 
assayed for binding. (A) Bound dexamethasone is expressed 
as occupied sites per cell. (B) The data are replotted for the 
initial 60 mln as ln ([free dexamethasone]/[unoccupied 
receptor sites]). Total receptor concentrations were estimated 
from binding at 3-4 h incubation. 
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Glucocorticoid responsiveness and kinetics of receptor-dexamethasone interaction 
Cell line Glucocorticoid Association 
response rate constant 
(phenotype) k, (min-r . M’l)a 
Dissociation 
rate constant 
kd (min-‘) 
Half-life 
t 112 
(mirQb 
Equilibrium 
dissociation 
constant 
Kd (nkOC 
WEHI- Sensitive (wt)d‘ 1.18 f 0.23 x lo6 (3) 1.24 i 0.35 x lo-” (3) 243 1.05 
s49.1 Sensitive (wt) 1.21 f 0.13 x 1o-3 (2) 249 
S49.1TB.4 Sensitive (wt) 1.38 i 0.31 x 10” (3) 1.19 f 0.11 x 1o-3 (3) 253 0.86 
S49.1G.3 Sensitive (wt) 0.86 f 0.23 x 1O-a (2) 350 
S49.1TB.4.55R Resistant (nt’) 1.18 i 0.28 x lo6 (2) 0.87 * 0.07 x 1O-a (4) 346 0.74 
S49.1TB.4.22R Resistant (nt-) 1.35 f 0.10 x lo6 (2) 3.95 i 0.62 x lo-’ (4) 76 2.92 
S49.1G.3.83R Resistant (nt-) 0.82 i 0.05 x lo6 (4) 1.24 * 0.02 x 1O-a (2) 243 1.51 
a Mean values and standard deviations are given (number of separate xperiments in parenthesis) 
b t,,, was calculated from the dissociation rate constant 
’ Equilibrium dissociation constant was calculated from rate constants k, and kd 
d wt signifies wild-type glucocorticoid sensitivity 
centrations. Nevertheless, the computed equilibrium 
dissociation constants of table 1 compare quite well 
to those obtained from equilibrium binding studies 
for lines WEHI- and S49.1 [22]. 
4. Discussion 
A careful study of the thermodynamics of gluco- 
corticoid binding to the receptors of hepatoma cells 
I I 
30 60 90 120 150 1.30 
Time lmtn I
Fig.2. Kinetics of dexamethasone dissociation from receptor 
complexes. Displacement of [ sH]dexamethasone from pre- 
labelled receptor complexes was measured as in section 2. 
The data are plotted as % of initial binding on a logarithmic 
scale. Symbols are as in fig.1 except that data for line S49.- 
lG3.83R (0) are also shown. 
[23] has led to the view that hydrophobic interactions 
between receptor and steroid account for most of the 
binding energy. The steroid binding site of the 
receptor can thus be viewed as a hydrophobic domain 
within the polypeptide structure. It is interesting in 
this regard that ghrcocorticoids of varying structures 
associate with the same rate constant with receptors 
of rat thymocytes and mouse L-cells [ 18,201. Similarly, 
as shown here, the rate of association of dexametha- 
sone with receptors of several mouse lymphoma cell 
clones was the same independent of whether these 
clones were of wild-type glucocorticoid sensitivity or 
whether they contained receptors with altered nuclear 
binding properties. Thus the association of gluco- 
corticoids with receptors of different cells appears to 
be rather invariant. 
However, the dissociation rate of receptor-gluco- 
corticoid complexes varies greatly with the structure 
of the steroid as has been shown for receptors of 
thymocytes [181 and Cells [20]. There are also 
substantial differences in the dissociation rate con- 
stantsof receptor complexes of different cell types 
with the same steroid, for example, dexamethasone 
[ 16-201. Thus the dissociation rates of receptor com- 
plexes appear to be quite sensitive to alterations in 
both ligand and receptor structures. It is therefore 
significant that the dexamethasone complex with the 
receptors of one of our nt--resistant lymphoma cell 
variants (849.1TB.4.22R) dissociates much more 
rapidly than that of the other clones. This clone, as 
93 
Volume 138, number 1 FEBS LETTERS February 1982 
well as the other variant clones used here has been 
obtained by a single-step isolation procedure [24] 
which is likely to yield single rather than multiple 
mutations in a specific gene product. It is therefore 
probable that a single genetic event in clone S49.1 TB.- 
4.22R has affected both the steroid binding site and 
the nuclear interaction domain of the receptor mole- 
cule . Definite proof for this view, however, will 
require detailed protein analytical studies with pure 
receptors. Nevertheless, these data support he general 
idea of a bifunctional structure of steroid hormone 
receptors which comprise within a single molecular 
entity 2 active domains, one for steroid binding and 
the other for interaction with chromatin. 
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